Insider · CIK 0002030200
Peter Miles Winston Davies
Files at NEUP (Neuphoria Therapeutics Inc.). First filing -, latest -.
Peter Miles Winston Davies files SEC Form 4 as director at NEUP (Neuphoria Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Miles Winston Davies has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | NEUP Neuphoria Therapeutics Inc. | AGrant or award Restricted Stock Unitsderivative | +8,537 | $0.00 | $0 | 15,320 | Jan 21, 2026 |
| Apr 16, 2025 | NEUP Neuphoria Therapeutics Inc. | AGrant or award Restricted Stock Unitsderivative | +6,783 | $0.00 | $0 | 6,783 | Apr 18, 2025 |
Questions about Peter Miles Winston Davies
Answered from the filings on this page, as of the latest one.
Is Peter Miles Winston Davies buying or selling?
Peter Miles Winston Davies has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Miles Winston Davies's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Miles Winston Davies has 0.
Where does Peter Miles Winston Davies file Form 4?
Peter Miles Winston Davies has filed Form 4 at NEUP (Neuphoria Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.